COVID-19 and arterial hypertension: Hypothesis or evidence?

摘要: Investigations reported that hypertension, diabetes, and cardiovascular diseases were the most prevalent comorbidities among patients with coronavirus disease 2019 (COVID-19). Hypertension appeared consistently as risk factors in COVID-19 patients. Some investigations speculated about association between renin-angiotensin-aldosterone system (RAAS) susceptibility to COVID-19, well relationship RAAS inhibitors increased mortality these This raised concern potential hypertension (and its treatment) propensity for COVID-19. There are only a few follow-up studies investigated impact of on outcome conflicting findings. has been proven be more an adverse (admission intensive care unit, use mechanical ventilation, or death). So far, there is no study demonstrated independent predictive value many speculations this relation different underlying diseases. The aim review was summarize current knowledge role